Better Buy: Bluebird Bio Vs. Novavax

Who wins this face-to-face between two beaten-down biotechs?If there is one thing Bluebird Bio (BLUE -5.17%) and Novavax (NVAX -0.47%) have in common, other than their belonging to the biotech industry, it is that both have seen their shares drop catastrophically in recent years. Bluebird's stock is down by 91% in the past three years, while Novavax's has declined by 97%.The market doesn't have much faith in either company, but if they can turn things around, opportunistic investors who initiate positions n ...